Rising Adoption of Structural Heart Devices in Emerging Countries to Thrive Market!
In the past few decades, the prevalence of the disease is surging at its wildest level. There is steep growth in the number of patients suffering cardiac diseases along with other diseases such as diabetes among others. According to the Centers for Disease Control and Prevention (CDC), cardiac diseases is the chief cause of death for men, women, and people of most racial and ethnic groups in the United States. Every 36 seconds, one person in the United States dies from cardiovascular disease. Around 659,000 people in the United States die from heart disease every year which is estimated to be around 1 in every 4 deaths. Every year, about 805,000 people in the United States have a heart attack.
Also, the number of people suffering from diabetes is also increasing. According to the Centers for Disease Control and Prevention (CDC) around 34.2 million people are living with diabetes in the U.S. Every year, more than 1.6 million people die of the disease. In which, the prevalence of diagnosis and mortality is higher in the aging population. Thus, rising disease prevalence is anticipated to boost the Structural Heart Devices which in turn is anticipated to boost the market growth.
- According to CDC, around 34.2 million people are suffering from diabetes (US population). Whereas, 26.9 million people, including 26.8 million adults are diagnosed while 7.3 million people (21.4% are undiagnosed).
- According to the Centers for Disease Control and Prevention (CDC) In the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack of which around 605,000 are first heart attacks and 200,000 happen to people who have already had a heart attack.
What Will Be the Market By 2028?
Our report on Structural Heart Devices Market has covered the study of the latest development and investment in the market. Moreover, the report covers the value chain analysis, regulatory analysis, market attractiveness analysis, and Porter’s five forces analysis, for Structural Heart Devices Market. In addition, our report includes market drivers, restraints, and opportunities along with COVID-19 impact analysis, historical & descriptive analysis, and forecasts & predictive analysis.
The Global Structural Heart Devices Market is expected to reach over USD 22.82 Billion in the year 2028 at Compound Annual Growth Rate (CAGR) of 9.50%.
Some of key players in Structural Heart Devices Market include - Medtronic plc; Braile Biomedica, St. Jude Medical, Inc., Medical Technology Est., Micro Interventional Devices, Inc., Boston Scientific Corporation; LivaNova PLC, Edwards Lifesciences Corporation, Cryolife, Inc., and JenaValve Technology, Inc..
North America is anticipated to hold the largest share of the Structural Heart Devices Market over the forecast period owing to the presence of an increasing number of patients along with investments in R&D from the government and several key players. The Asia Pacific is estimated to grow at the fastest Compound Annual Growth Rate for Structural Heart Devices Market over the forecast period of 2021-2028.